Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIVNadine Jaschinski, Lene Ryom, Cristina Mussini et al.|AIDS|2022Cited by 38
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency VirusFrédérique Chammartin, Amanda Mocroft, Alexander Egle et al.|Clinical Infectious Diseases|2023Cited by 27
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom et al.|Clinical Infectious Diseases|2023Cited by 23
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIVLauren Greenberg, Lene Ryom, Elżbieta Bąkowska et al.|Cancers|2023Cited by 19
Incident tuberculosis in people with HIV across Europe from 2012 to 2022: incidence rates, risk factors and regional differences in a multicentre cohort studyChristian Kraef, Ashley Roen, Daria Podlekareva et al.|European Respiratory Journal|2025Cited by 12